Angela Waanders, MD, MPH

Clinical and Community Trials

Biography

  • Head, Neuro-Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Director, Precision Medicine Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Executive Board Chair, Children's Brain Tumor Tissue Consortium, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Gus Foundation Chair in Neuro-Oncology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in pediatric hematology/oncology, Children's Hospital of Philadelphia 2006-2009
  • Residency is pediatrics, Children's Hospital of Philadelphia 2003-2006
  • MD, Tulane University School of Medicine 2003

Clinical Studies

Recruiting

Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas (PNOC021)

Recruiting

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Recruiting

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

Publications

Nov. 17, 2023

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

May. 31, 2023

OpenPBTA: The Open Pediatric Brain Tumor Atlas.

May. 16, 2023

An International Pediatric-Onset Opsoclonus-Myoclonus Ataxia Syndrome Registry and Clinical Research Network: Development, Progress, and Vision.

See all publications

Similar Researchers

Basic and Preclinical Science

Kevin McNerney, MD

Research Interests

CAR T-cell Therapy, CAR T-cell Toxicities, Immunotherapy, Hematopoietic Stem Cell Transplant, Leukemia

Recent Publication

Mediport use as an acceptable standard for CAR T cell infusion.

Oct. 27, 2023
Clinical and Community Trials

Jeremy N. Wong, MD

Recent Publication

A comprehensive wireless neurological and cardiopulmonary monitoring platform for pediatrics.

Jul. 06, 2023

Brian E. Nolan, MD

Recent Publication

A specialized multi-disciplinary care program for children with sepsis and multiple organ dysfunction-associated immune dysregulation.

Jan. 01, 2022
Clinical and Community Trials

Todd Florin, MD, MSCE

Research Interests

Pediatric Respiratory Infections, Pediatric Emergency Medicine, Clinical and Molecular Epidemiology, Antimicrobial Stewardship, Predictive Analytics

Recent Publication

Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.

Mar. 26, 2024
Clinical and Community Trials

Joshua B. Ewen, MD

Research Interests

Cognition in Developmental Disabilities (Autism, ADHD), Epilepsy, Brain-Behavior Relationships, Theory-Based Psychology, Motor Control, Biomarker Validation

Erin Bressler, MD